"Sentara Neurology Specialists is a group of doctors that diagnose and treat disorders of the brain, spinal cord and nervous system. A Department of Sentara Princess Anne Hospital."

During the past decade, Sentara Neurology Specialists conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 11 clinical trials were completed, i.e. on average, 78.6% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 9 clinical trials were completed. i.e. 300% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Sentara Neurology Specialists" #1 sponsor was "Eli Lilly and Company" with 3 trials, followed by "Allergan" with 2 trials sponsored, "Addex Pharma S.A." with 1 trials sponsored, "Alexion" with 1 trials sponsored and "Chelsea Therapeutics" with 1 trials sponsored. Other sponsors include 5 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Sentara Neurology Specialists" #1 collaborator was "Michael J. Fox Foundation for Parkinson's Research" with 2 trials as a collaborator, "National Institute of Neurological Disorders and Stroke (NINDS)" with 2 trials as a collaborator, "The Parkinson Study Group" with 2 trials as a collaborator, "INC Research Limited" with 1 trials as a collaborator and "Stryker Neurovascular" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Sentara Neurology Specialists" are "Parkinson's Disease" (6 trials), "Parkinson Disease" (4 trials), "ALS" (2 trials), "Migraine, With or Without Aura" (2 trials) and "Amyotrophic Lateral Sclerosis" (1 trials). Many other conditions were trialed in "Sentara Neurology Specialists" in a lesser frequency.

Most popular intervention types in "Sentara Neurology Specialists" are "Drug" (17 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (10 trials), "Galcanezumab" (2 trials), "Placebo-matching Ubrogepant" (2 trials), "Ubrogepant" (2 trials) and "APL-130277" (1 trials). Other intervention names were less common.

The vast majority of trials in "Sentara Neurology Specialists" are 18 trials for "All" genders.

Currently, there are NaN active trials in "Sentara Neurology Specialists". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in Sentara Neurology Specialists, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Sentara Neurology Specialists, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".